Trove Therapeutics
PrivateCompany Overview
Trove Therapeutics is a biopharmaceutical company developing a novel therapeutic protein platform based on secretoglobins to treat respiratory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticaltherapeutic proteinsecretoglobinSCGB1A1respiratory diseasebiotechrecombinant proteinreplacement therapyclinical-stagedrug developmentairway repairbiologicsclinical trialsautoimmune conditionspipeline drug
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trove Therapeutics Comparables
Compare Trove Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AATec Medical GmbH | 79% | |
| Airway Therapeutics | 77% | |
| BioAegis Therapeutics | 73% | |
Trove Therapeutics Funding Rounds
Historical fundraising activity
Trove Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trove Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?